{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:11:38Z","timestamp":1767924698901,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Ministry of Education and Science","award":["13N13399"],"award-info":[{"award-number":["13N13399"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jad.2020.07.125","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T12:04:09Z","timestamp":1596283449000},"page":"450-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder"],"prefix":"10.1016","volume":"277","author":[{"given":"Edgar Arrua","family":"Vares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathrin","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Soltmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.07.125_bib0001","first-page":"207","article-title":"Depression and inflammation: is there any role for biomarkers?","volume":"11","author":"Akhondzadeh","year":"2019","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"10.1016\/j.jad.2020.07.125_bib0002","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-kappa B in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jad.2020.07.125_bib0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bdi.12259","article-title":"Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls","volume":"17","author":"Bai","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360481","article-title":"Cytokines in bipolar disorder: paving the way for neuroprogression","volume":"2014","author":"Barbosa","year":"2014","journal-title":"Neural Plast."},{"key":"10.1016\/j.jad.2020.07.125_bib0005","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2020.07.125_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40345-015-0037-x","article-title":"Inflammatory monocyte gene expression: trait or state marker in bipolar disorder?","volume":"3","author":"Becking","year":"2015","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0007","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2020.07.125_bib0008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1871530318666180131094733","article-title":"Relationship between proinflammatory cytokines\/chemokines and adipokines in serum of young adults with obesity","volume":"18","author":"Borges","year":"2018","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.jad.2020.07.125_bib0009","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbi.2009.04.008","article-title":"Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder","volume":"23","author":"Brietzke","year":"2009","journal-title":"Brain Behav. Immunity"},{"key":"10.1016\/j.jad.2020.07.125_bib0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.125_bib0012","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2020.07.125_bib0013","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jad.2020.07.125_bib0014","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/157340006778699729","article-title":"Trait vs. State Markers for Schizophrenia: Identification and Characterization through Visual Processes","volume":"2","author":"Chen","year":"2006","journal-title":"Curr. Psychiatry Rev."},{"key":"10.1016\/j.jad.2020.07.125_bib0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.psychres.2015.07.078","article-title":"Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder","volume":"229","author":"Coccaro","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.125_bib0016","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4088\/JCP.v66n0814","article-title":"Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic\/hypomanic and depressive symptoms","volume":"66","author":"Constant","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2020.07.125_bib0018","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acps.12656","article-title":"Interleukin-1 beta-targeted treatment strategies in inflammatory depression: toward personalized care","volume":"134","author":"Ellul","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2020.07.125_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl 2","key":"10.1016\/j.jad.2020.07.125_bib0020","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation","volume":"8","author":"Gabay","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jad.2020.07.125_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5114\/reum.2018.77969","article-title":"Interleukin 17 and Treg - a common pathomechanism and a new target of therapy in rheumatic diseases and depression","volume":"56","author":"Galecki","year":"2018","journal-title":"Reumatologia"},{"key":"10.1016\/j.jad.2020.07.125_bib0023","series-title":"Manic Depressive Ilness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"10.1016\/j.jad.2020.07.125_bib0025","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2020.07.125_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2020.07.125_bib0027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0028","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archpsyc.62.12.1322","article-title":"Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study","volume":"62","author":"Judd","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0029","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.125_bib0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/mp.2009.112","article-title":"A systemic toxicity index developed to assess peripheral changes in mood episodes","volume":"15","author":"Kapczinski","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0032","first-page":"75","article-title":"[Inflammation and neurodegeneration in patients with early-stageand chronic bipolar disorder]","volume":"30","author":"Karabulut","year":"2019","journal-title":"Turk. Psikiyatri Derg."},{"key":"10.1016\/j.jad.2020.07.125_bib0033","series-title":"Manic Depressive Insanity and Paranoia","author":"Kraepelin","year":"1921"},{"key":"10.1016\/j.jad.2020.07.125_bib0034","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cyto.2015.07.010","article-title":"The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid","volume":"76","author":"Larsson","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jad.2020.07.125_bib0036","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.4049\/jimmunol.1001536","article-title":"IL-1beta-mediated signals preferentially drive conversion of regulatory T cells but not conventional T cells into IL-17-producing cells","volume":"185","author":"Li","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jad.2020.07.125_bib0038","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2008.07.006","article-title":"The functional impact of subsyndromal depressive symptoms in bipolar disorder: data from STEP-BD","volume":"114","author":"Marangell","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/acps.12783","article-title":"Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study","volume":"136","author":"Morch","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2020.07.125_bib0041","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.jad.2020.07.125_bib0042","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.125_bib0043","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1021\/cn500038f","article-title":"Effects of lithium on inflammation","volume":"5","author":"Nassar","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jad.2020.07.125_bib0044","article-title":"Effects of risperidone on cytokine profile in drug-naive first-episode psychosis","volume":"18","author":"Noto","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.07.125_bib0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cyto.2007.03.006","article-title":"Effect of storage temperatures on the stability of cytokines in cervical mucous","volume":"37","author":"Panicker","year":"2007","journal-title":"Cytokine"},{"key":"10.1016\/j.jad.2020.07.125_bib0046","article-title":"Melatonin suppression by melanopsin-weighted light in patients with bipolar I disorder compared to healthy controls","volume":"44","author":"Ritter","year":"2019","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2020.07.125_bib0047","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2014.02.004","article-title":"The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research","volume":"42","author":"Rizzo","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2020.07.125_bib0048","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/acps.12414","article-title":"Are medical comorbid conditions of bipolar disorder due to immune dysfunction?","volume":"132","author":"Rosenblat","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2020.07.125_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci7110144","article-title":"Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications","volume":"7","author":"Rosenblat","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.jad.2020.07.125_bib0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2020.07.125_bib0051","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2020.07.125_bib0052","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jad.2020.07.125_bib0053","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11126-011-9191-1","article-title":"Pharmacological treatment of bipolar depression: qualitative systematic review of double-blind randomized clinical trials","volume":"83","author":"Spanemberg","year":"2012","journal-title":"Psychiatry Q."},{"key":"10.1016\/j.jad.2020.07.125_bib0054","first-page":"76","article-title":"Global Assessment of Functioning (GAF) Scale","author":"Spitzer","year":"1996","journal-title":"Outcomes Assess. Clin. Pract."},{"key":"10.1016\/j.jad.2020.07.125_bib0057","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fpsyt.2018.00250","article-title":"Markers of inflammation and monoamine metabolism indicate accelerated aging in bipolar disorder","volume":"9","author":"van den Ameele","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0058","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pnpbp.2017.04.026","article-title":"Effect of antidepressant treatment on peripheral inflammation markers \u2013 a meta-analysis","volume":"80","author":"Wiedlocha","year":"2018","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.07.125_bib0059","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2017.03.003","article-title":"Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder","volume":"307","author":"Wiener","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jad.2020.07.125_bib0060","unstructured":"Wittchen H-U., F.T., Zaudig M., et\u00a0al., 1997. SKID: Strukturiertes Klinisches Interview f\u00fcr DSM-IV; Achse I und II. Achse II: Pers\u00f6nlichkeitsst\u00f6rungen. SKID-II. Hogrefe, G\u00f6ttingen."},{"key":"10.1016\/j.jad.2020.07.125_bib0061","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:43:21Z","timestamp":1759023801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720325787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":55,"alternative-id":["S0165032720325787"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.125","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of pro-inflammatory cytokines with clinical features in euthymic patients with Bipolar-I-Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}